Literature DB >> 24045283

High-sensitivity C-reactive protein level is an independent predictor of poor prognosis in cirrhotic patients with spontaneous bacterial peritonitis.

Yuri Cho1, So Youn Park, Jeong-Hoon Lee, Dong Hyeon Lee, Minjong Lee, Jeong-Ju Yoo, Won-Mook Choi, Young Youn Cho, Yun Bin Lee, Jae Woong Yoon, Jung Hee Kwon, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Chung Yong Kim, Hyo-Suk Lee.   

Abstract

BACKGROUND/AIMS: The production of high-sensitivity C-reactive protein (hs-CRP) may be affected by hepatic function, and the clinical importance of hs-CRP in patients with liver cirrhosis is still not clear. The aim of this study was to evaluate the clinical implications of hs-CRP in cirrhotic patients with spontaneous bacterial peritonitis (SBP).
METHODS: We retrospectively investigated 336 consecutive patients treated for SBP from 2007 to 2012. The relationship between serum hs-CRP and the result of the treatment was assessed.
RESULTS: A response to antibiotics was observed in 182 patients (54.2%), and 126 patients (37.5%) died of SBP. The initial hs-CRP (odds ratio=1.061, P=0.016), coexistent hepatocellular carcinoma, and Child-Pugh (CP) score were independent prognostic factors for high in-hospital mortality. Serum hs-CRP level was also an independent predictor of lower antibiotic response rate (odds ratio=0.916, P<0.001). However, hs-CRP was negatively correlated with the CP score (r=-0.199, P<0.001) and Model for End-Stage Liver Disease score (r=-0.182, P=0.001).
CONCLUSIONS: This study found that serum hs-CRP level is related to a lower response rate to antibiotics, a higher mortality rate in patients with SBP. The hs-CRP level was negatively correlated with the CP and Model for End-Stage Liver Disease scores, which suggests that the prognostic function of hs-CRP was not a surrogate for hepatic dysfunction.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24045283     DOI: 10.1097/MCG.0b013e3182a6cdef

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  6 in total

1.  Effect of L-Carnitine in Patients With Liver Cirrhosis on Energy Metabolism Using Indirect Calorimetry: A Pilot Study.

Authors:  Yoshiyuki Sakai; Hiroki Nishikawa; Hirayuki Enomoto; Kazunori Yoh; Yoshinori Iwata; Kunihiro Hasegawa; Chikage Nakano; Kyohei Kishino; Yoshihiro Shimono; Ryo Takata; Takashi Nishimura; Nobuhiro Aizawa; Naoto Ikeda; Tomoyuki Takashima; Akio Ishii; Hiroko Iijima; Shuhei Nishiguchi
Journal:  J Clin Med Res       Date:  2016-10-26

Review 2.  Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review.

Authors:  Toru Shizuma
Journal:  World J Hepatol       Date:  2018-02-27

3.  Role of ascitic prostaglandin E2 in diagnosis of spontaneous bacterial peritonitis and prediction of in-hospital mortality in patients with decompensated cirrhosis.

Authors:  Junli Luo; Xianmei Wu; Yu Zhang; Wenxiang Huang; Bei Jia
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

4.  The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis.

Authors:  Jung Hyun Kwon; Jeong Won Jang; Young Woon Kim; Sung Won Lee; Soon Woo Nam; Dongwook Jaegal; Seungok Lee; Si Hyun Bae
Journal:  BMC Gastroenterol       Date:  2015-10-23       Impact factor: 3.067

5.  Bacterascites: A study of clinical features, microbiological findings, and clinical significance.

Authors:  Rosalie C Oey; Henk R van Buuren; David M de Jong; Nicole S Erler; Robert A de Man
Journal:  Liver Int       Date:  2018-08-10       Impact factor: 5.828

Review 6.  Fluid Biomarkers for Predicting the Prognosis of Liver Cirrhosis.

Authors:  Si-Hai Chen; Qin-Si Wan; Ting Wang; Kun-He Zhang
Journal:  Biomed Res Int       Date:  2020-03-20       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.